Gerald, et al., “A Receptor Subtype involved in Neuropeptide-Y-. . . ”, Nature, vol. 382, pp. 168-171, Jul. 11, (1996). |
Hu, et al., “Identification of a Novel Hypothalamic Neuropeptide . . . ”, J. ofBiological Chem., vol. 271, No. 42, pp. 26315-26319, Oct. 18, (1996). |
Nakamura, et al., “Molecular cloning, organization and . . . ”, Biochimica et Biophysica Acta 1328 pp. 83-89, (1997). |
Schaffhauser, et al., “Inhibition of Food Intake by Neuropeptide Y Y5 . . . ”, Diabetes, vol. 46, pp. 1792-1798, Nov. (1997). |
Marsh, et al., “Role of the Y5 neuropeptide Y Receptor . . . ”, Nature Medicine, vol. 4, pp. 718-721, Jun. (1998). |
Widdowson, P.S., “Regionally-selective down-regulation of NPY Y5 . . . ”, Brain Research, 758, pp. 17-25, (1997). |
Xin, et al., “Down-Regulated NPY receptor subtype-5 mRNA . . . ”, NeuroReport 9, pp. 737-741, (1998). |
Bobowski, 3,4,9,9a Tetrahydro-1,4-ethano-3, 4a(iminoethano)-4aH-carbozol-2(1H)one Derivatives. (J. Org. Chem., 50(7), pp. 929-931), 1985. |
Bobowski, et al., 3,4,9,9a Tetrahydro-1,4-ethano-3,4a(iminoethano)-4aH-carbazol-2(1H)-one Derivatives and N,3-Disubstituted 3,3a,4,4a,10,10a-Hexahydro-3a-hydroxy-2oxo-1,9b:4, 10-dietanoimidazol[4,5-b]carbazole-5(2H)-carboxamide (J. Org. Chem., 46(24), pp. 4927-4931), 1981. |